Filed Pursuant to Rule 424(b)(5)Registration No. 333-296498 The information in this preliminary prospectus supplement is not complete and may be changed. A registration statementhas been filed with the Securities and Exchange Commission and is effective. This preliminary prospectus supplement andthe accompanying prospectus are not an offer to sell these securities and it is not soliciting an offer to buy these securities in Subject to completion, dated June 29, 2026 PRELIMINARY PROSPECTUS SUPPLEMENT(To Prospectus dated June 16, 2026) Shares of Common Stock Creative Realities, Inc. We are offeringshares of our common stock, par value $0.01 per share (the “common stock”), and pre-funded warrantsto purchaseshares of our common stock, includingshares of common stock underlying the pre-funded warrants. The Each pre-funded warrant is exercisable for one share of common stock at an exercise price of $0.01, which is equal to the parvalue per share of common stock being sold in this offering.The pre-funded warrants will be exercisable upon issuance, subject toan ownership limitation, and will not expire. See “Description of Securities we are Offering - Pre-Funded Warrants.” This Our common stock is listed on The Nasdaq Capital Market (“Nasdaq”) under the symbol “CREX”. On June 26, 2026, the lastreported sale price of our common stock on Nasdaq was $4.10 per share.There is no established public trading market for the pre-funded warrants and we do not expect a market to develop. In addition, we do not intend to list the pre-funded warrants on any As of June 29, 2026, the aggregate market value of our outstanding common stock held by non-affiliates was approximately$40.5 million, which was calculated based on 9,878,159 shares of common stock that were outstanding and held by non-affiliatesas of June 22, 2026 and a price per share of $4.10, the closing price of our common stock on Nasdaq on June 26, 2026. Pursuant toGeneral Instruction I.B.6. of Form S-3, in no event will we sell securities, registered on the registration statement of which thisprospectus supplement is a part, in a public primary offering with a value exceeding more than one-third of the aggregate marketvalue of our common stock in any 12 calendar month period so long as the aggregate market value of our outstanding common Investing in our securities involves risks. See“Risk Factors”beginning on page S-7of this prospectus supplement, page2 of the accompanying prospectus and under similar headings in the other documents that are incorporated by referenceinto this prospectus supplement and the accompanying prospectus. (1See the information in the section titled “Underwriting”in this prospectus supplement for a description of the compensation tobe received by the underwriter. We have granted the underwriter a30-dayoption to purchase up to anadditionalshares of common stock from us atthe public offering price, less underwriting discounts and commissions, and on the same terms and conditions as set forth above. Certain of our directors and officers have indicated an interest in purchasing up to $850,000 of shares of our common stock inthis offering at the public offering price. However, because indications of interest are not binding agreements or commitments topurchase, the underwriter could determine to sell more, less or no shares to any of these potential investors, and any of these Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved ofthese securities, or determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Anyrepresentation to the contrary is a criminal offense. The underwriter expects to deliver the shares of common stock and pre-funded warrants against payment therefor on orabout, 2026. Craig-Hallum , 2026 TABLE OF CONTENTS Prospectus Supplement PageAbout This Prospectus SupplementS-1Prospectus Supplement SummaryS-2 Prospectus ABOUT THIS PROSPECTUS SUPPLEMENT This prospectus supplement and the accompanying prospectus form part of a registration statement on Form S-3 that we filedwith the Securities and Exchange Commission (the “SEC”) using a “shelf” registration process. This document contains two parts.The first part consists of this prospectus supplement, which provides you with specific information about this offering. The secondpart, the accompanying prospectus, provides more general information, some of which may not apply to this offering. This To the extent that any statement we make in this prospectus supplement is inconsistent with statements made in theaccompanying prospectus or any documents incorporated by reference herein or therein, the statements made in this prospectussupplement will be deemed to modify or supersede those statements made in the accompanying prospectus and such documentsincorporated by reference herein and therein. Before investing in our securities, you should read this prospectus supplement a